In a significant move within the pharmaceutical industry, Krka, a leading international generic pharmaceutical company based in Novo Mesto, Slovenia, and Laurus Labs (“Laurus” or “the Company”), have announced the formation of a joint venture (JV) company, Krka Pharma Pvt. Ltd., in Hyderabad, India. The venture marks a new chapter in the longstanding relationship between […]
Laurus Labs Ltd., a prominent pharmaceutical and biotech R&D entity in India, has released its H1 FY24 financial results. The firm reported a revenue of ₹ 2,406 Cr and an EBITDA of ₹ 356 Cr. Q2 FY24 Financial Overview For Q2 FY24, Laurus Labs showcased: Revenue of ₹ 1,224 crs, witnessing a decrease of 22% […]
Hyderabad-based pharmaceutical company Laurus Labs has announced a significant investment in Immunoadoptive Cell Therapy (lmmunoACT), an advanced cell and gene therapy firm. The deal, valued at INR 80 crores, will increase Laurus Labs’ stake in ImmunoACT to 33.86% on a fully diluted basis. This strategic move is expected to provide ImmunoACT with the necessary capital […]
Laurus Labs said that it has acquired a stake of 26.62% in Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an Indian cell and gene therapy company for a sum of around INR 46 crores in cash. Apart from that, ImmunoACT will also get an investment of INR 9.75 crores from its senior management for a stake […]